QUEST DIAGNOSTICS INC
DGX
DELAYED 1 MONTH
38 insider filings · Latest: Jul 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Jul 29 9:04 PM | Mark E DelaneySVP & Chief Commercial Officer | Sale | 1,600 | $235.18 | $376.3K | 10,335(D) | View → |
| Jun 4, 2026 | Jun 8 8:32 PM | Karthik KuppusamySVP, Clinical Solutions | Sale | 8,147 | $200.00 | $1.6M | 13,510(D) | View → |
| Jun 1, 2026 | Jun 2 10:38 PM | E. J. DavisDirector, CEO and President | Sale | 10,000 | $194.14 | $1.9M | 132,423(D) | View → |
| Mar 5, 2026 | Mar 6 9:45 PM | Catherine T. DohertyEVP, Regional Businesses | Sale | 5,558 | $206.21 | $1.1M | 67,122(D) | View → |
| Mar 5, 2026 | Mar 6 9:44 PM | Michael E PrevoznikSVP & General Counsel | Sale | 3,878 | $206.21 | $799.7K | 37,557(D) | View → |
| Mar 5, 2026 | Mar 6 9:44 PM | Patrick PlewmanSVP for Diagnostic Services | Sale | 2,855 | $206.21 | $588.7K | 15,198(D) | View → |
| Mar 4, 2026 | Mar 6 9:43 PM | Karthik KuppusamySVP, Clinical Solutions | Sale | 2,628 | $204.86 | $538.4K | 13,441(D) | View → |
| Mar 3, 2026 | Mar 4 9:39 PM | Catherine T. DohertyEVP, Regional Businesses | Sale | 632 | $207.73 | $131.3K | 67,122(D) | View → |
| Mar 3, 2026 | Mar 4 9:38 PM | Michael E PrevoznikSVP & General Counsel | Sale | 526 | $207.73 | $109.3K | 37,557(D) | View → |
| Mar 2, 2026 | Mar 4 9:38 PM | E. J. DavisDirector, CEO and President | Sale | 10,000 | $212.52 | $2.1M | 117,185(D) | View → |
| Mar 3, 2026 | Mar 4 9:38 PM | Patrick PlewmanSVP for Diagnostic Services | Sale | 410 | $207.73 | $85.2K | 15,198(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8 8:32 PM | Karthik KuppusamySVP, Clinical Solutions | Option Exercise | 8,147 | $127.73 | 0(D) | View → |